openPR Logo
Press release

Transdermal and Transmucosal Drug Delivery Systems Market - Analysis, Technologies & Forecasts 2025

02-09-2018 07:13 AM CET | Health & Medicine

Press release from: TMR Research

Transdermal and Transmucosal Drug Delivery Systems Market - Analysis, Technologies & Forecasts 2025

Global Transdermal and Transmucosal Drug Delivery Systems Market: Snapshot

Transdermal and transmucosal drug delivery systems as alternative drug delivery routes have gained traction in clinical practices over the past few decades. The need for these systems is driven by the growing demand for controlled drug delivery to achieve a number of clinical objectives. These delivery systems have been found to be useful for improving pharmacological response of drugs and their efficacy. Marked difficulty in developing new chemical entities and the considerable time gap for their approval have persuaded various pharmaceutical companies to focus on improving the therapeutic outcomes of the already approved drugs. Alternative delivery systems are developed to achieve this objective and increase patient compliance. In recent years, transdermal drug delivery system (TDDS) has been found to be promising for developing novel drug delivery systems.

A transdermal drug delivery system also known as transdermal patches offer several advantages over common types of drug delivery systems such as topical, oral, intravenous, and intramuscular. The mechanism includes controlled delivery drugs into systemic circulation through the skin and into the bloodstream of patients at a predetermined rate and for a long duration without being affected by intra and inter patient variations. Key advantages comprise overcoming the limitation of first-pass metabolism through liver and maintaining a steady plasma level of drugs administered. The development of TDDS helps in bringing the release of intended medications at zero order rate. As a result, they are preferred for prophylactic therapies in various chronic conditions. However, the adoption of TDDS in the mainstream medication delivery seems to be crippled by several constraints. Some of the notable limitations of TDDS include the inability of the system to deliver ionic drugs and drugs cannot be delivered in a pulsatile manner. Further feasibility studies spanning multiple disciplines are needed to demonstrate the efficacy and viability of transdermal and transmucosal drug delivery systems, including patient comfort and economy of these systems.

Request Sample Copy of the Report@ www.tmrresearch.com/sample/sample?flag=B&rep_id=123

Global Transdermal and Transmucosal Drug Delivery Systems Market: Brief Overview

Transdermal drug delivery systems (TDDS) generally known as patches, are the systems use intact skin, as a mean of administering drug into the circulation system of the body. A transdermal patch is a free separate dose form which when applied on the skin, transports the medication at a precise and organized rate. The first transdermal system was approved by the FDA in 1979 for the treatment of vomiting and nausea. There are several benefits associated with transdermal and transmucosal drug delivery systems such as they evade first pass effect, decrease multiple dosage, avoid chemically unfriendly GI environment, improve patient compliance, permit use of drugs with short shelf life, provide a controlled release of very potent drugs and drug input can be easily interrupted when toxicity occurs.

This industry research report is a brief review of the growth trail in terms of current, historical, and future scenarios of the global transdermal and transmucosal drug delivery systems market. It offers an evaluation of the aspects that are expected to influence the development of the market and the primary trends have also been specified in the research study. The research study also offers a broad lookout on the vendor landscape of the market through Porter’s five forces analysis. The research publication provides references of mergers and acquisitions, the research and development activities, specifics on licensing and collaborations. The report probes into the strategies related to marketing, shares, and product portfolio of the key participants in the global transdermal and transmucosal drug delivery systems market.

Request TOC of the Report @ www.tmrresearch.com/sample/sample?flag=T&rep_id=123

Global Transdermal and Transmucosal Drug Delivery Systems Market: Emerging Trends

The transdermal and transmucosal drug delivery systems market is exhibiting a commendable growth owing to the high incidence rate of chronic diseases such as diabetes and hypertension. Moreover, ghoulish lifestyle practices, extreme alcohol consumption, and the consumption of drugs such as amphetamines and cocaine among people are the chief factors triggering heart disease, further augmenting the growth of transdermal and transmucosal drug delivery systems market. However, an upsurge in overall healthcare expenditure, severe regulatory policies, and high costs of clinical trials are some of the factors are likely to impede the growth of TDDS system. Presently, transdermal and transmucosal drug delivery systems market is an extremely fragmented and reputed market owing to the participation of many recognized as well as emerging players in the industry.

Global Transdermal and Transmucosal Drug Delivery Systems Market: Regional Analysis

Geographically, North America is the leading market for transdermal and transmucosal drug delivery systems owing to the high incidence rate of cardiac diseases along with the increasing base of brain disorder patients. A sizeable number of such patients are expected to drive the market growth for transdermal and transmucosal drug delivery systems. However, other regions such as South East Asia, Middle East and Latin America are also projected to be the prospective markets in the future for vendors.

Enquiry For Discount @ www.tmrresearch.com/sample/sample?flag=D&rep_id=123

Global Transdermal and Transmucosal Drug Delivery Systems Market: Vendor Landscape

Some of key participants in the market are Medipatch, Inc., Aveva Drug Delivery Systems, 3M Pharmaceuticals, DURECT Corporation, ALZA Corporation, and TEVA Pharmaceutical Industries Ltd.

About TMR Research

TMR Research is a premier provider of customized market research and consulting services to business entities keen on succeeding in today’s supercharged economic climate. Armed with an experienced, dedicated, and dynamic team of analysts, we are redefining the way our clients’ conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends.

Our savvy custom-built reports span a gamut of industries such as pharmaceuticals, chemicals and metals, food and beverages, and technology and media, among others. With actionable insights uncovered through in-depth research of the market, we try to bring about game-changing success for our clients.

Contact:

TMR Research,
3739 Balboa St # 1097,
San Francisco, CA 94121
United States
Tel: +1-415-520-1050
Email: sales@tmrresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Transdermal and Transmucosal Drug Delivery Systems Market - Analysis, Technologies & Forecasts 2025 here

News-ID: 937705 • Views: 116

More Releases from TMR Research

Healthcare Regulatory Affairs Outsourcing Market - Overview On Upcoming Need 202 …
Global Healthcare Regulatory Affairs Outsourcing Market: Snapshot The healthcare regulatory affairs outsourcing market is experiencing significant growth owing to services to Clinical Research Organizations. The rising number of patent expirations along with growing costs of research and development activities are the primary factors influencing the growth of the global healthcare regulatory affairs outsourcing market. Healthcare and biopharmaceutical organizations are likely to team up with numerous outsourcing companies for getting their drugs
Physician Office Laboratory (POL) Market - Current Opportunities 2025 | Accriva …
Global Physician Office Laboratory (POL) Market: Snapshot The global Physician Office Laboratory (POL) Market has been expanding substantially over the last few years. Supported by the technological advancements, the market is likely to remain proliferating over the next few years. POL testing has its base in developed regions as emerging economies still rely on hospital infrastructure for the diagnosis of acute and chronic medical conditions. Developing regions, however, has been demonstrating
Urological Catheters Market - Insights On Scope 2025 | Bard Medical, Rochester M …
Global Urological Catheters Market: Snapshot Catheters are medical instruments that are commonly used when a patient is unable to empty his or her bladder. If urine is allowed to build up in the patient’s bladder for a long time, the rising pressure in the kidneys can lead to kidney failure. The elderly people and patients with severe illness or injuries might need to use catheters for longer periods of time than
Tinnitus Market - Comprehensive Survey On Demand 2025 | Auris Medical Holding AG …
Global Tinnitus Market: Snapshot The global tinnitus market exhibited impressive growth in the recent past as the number of people suffering from tinnitus has been increasingly continuously. Tinnitus is a physical condition that occurs within an ear when there is no external noise mainly considered as a hearing perception. In most of the cases tinnitus occurs due to fluctuation in cochlea’s nerve activity as the auditory inputs are reduced. There are

All 25863 Releases


More Releases for Transdermal Drug Delivery

Therapeutic Landscape of Transdermal Drug Delivery Pipeline
Summary The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Transdermal Drug Delivery pipeline products. GET SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/3090629-transdermal-drug-delivery-medical-devices-pipeline-assessment-2018 Scope -
Transdermal Drug Delivery Systems Market – Trends 2025
A transdermal drug delivery systems (TDDS) is a medicated adhesive bandage or a patch that is stuck onto the skin to deliver a dose of drug through the skin and in the bloodstream. This patch promotes faster healing of injuries on the body, delivers a steady infusion of the drug over a time period and increases the therapeutic value of drugs by avoiding problem associated with drug. This is a
Transdermal Drug Delivery System Market 2017 -
Apex Research, recently published a detailed market research study focused on the "Transdermal Drug Delivery System Market" across the global, regional and country level. The report provides 360° analysis of "Transdermal Drug Delivery System Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Transdermal Drug Delivery System industry, and estimates the future
Transdermal Drug Delivery Market & Clinical Pipeline Insight
Transdermal drug delivery system, over the past decades, has emerged as a major tool for treating diseases of the skin. The major underlying factor driving this method is that the human skin is the most readily accessible surface for the delivery of drugs. A transdermal patch is defined as a medicated adhesive patch which is placed on the skin for delivering a specific dose of medication through the layers of